Contents
Executive Summary vii
1 Introduction 1
2 Drug Price Regulations in Selected OECD Countries—An Overview of the Issues 3
3 Price And Revenue Effects 10
4 Impact of Deregulating Prices on Research and Development, Innovation, and
Consumers 25
Appendix A: Technical Methodology 35
Appendix B: Drug Pricing Study—Federal Register Notice Responses 49
Appendix C: Report on Pharmaceutical Markets in 11 OECD Countries 57